Reasons for discontinuation of direct oral anticoagulant therapy in patients with non-valvular atrial fibrillation

被引：0
|
作者：
Renner, Elizabeth [1 ]
Mouland, Erin [1 ]
Saad, Samira [1 ]
Ha, Nghi [1 ]
Kim, Pauline [2 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Indiana Univ Hlth, Indianapolis, IN USA
来源：
JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 2019年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11
引用
收藏
页码：617 / 618
页数：2
相关论文
共 50 条
  • [1] Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation
    Mehmet Agirbasli
    [J]. Journal of Thrombosis and Thrombolysis, 2018, 46 : 570 - 570
  • [2] Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation
    Agirbasli, Mehmet
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (04) : 570 - 570
  • [3] Quality Of Direct Oral Anticoagulant Prescribing In Elderly Patients With Non-Valvular Atrial Fibrillation
    Grant, S. J.
    Kothari, S.
    Gimotty, P.
    Gooneratne, N.
    Cuker, A.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S73 - S73
  • [4] Creatinine monitoring patterns in the setting of direct oral anticoagulant therapy for non-valvular atrial fibrillation
    Martin M. Gruca
    Yun Li
    Xiaowen Kong
    Deborah DeCamillo
    Eva Kline-Rogers
    Mona A. Ali
    Scott Kaatz
    Musa Dahu
    James B. Froehlich
    Geoffrey D. Barnes
    [J]. Journal of Thrombosis and Thrombolysis, 2019, 48 : 500 - 505
  • [5] Creatinine monitoring patterns in the setting of direct oral anticoagulant therapy for non-valvular atrial fibrillation
    Gruca, Martin M.
    Li, Yun
    Kong, Xiaowen
    DeCamillo, Deborah
    Kline-Rogers, Eva
    Ali, Mona A.
    Kaatz, Scott
    Dahu, Musa
    Froehlich, James B.
    Barnes, Geoffrey D.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (03) : 500 - 505
  • [6] Reasons for discontinuation of novel oral anticoagulant therapy in patients with atrial fibrillation
    Mitrovic, Darko
    Folkeringa, Richard
    Veeger, Nic
    van Roon, Eric
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (04) : 547 - 553
  • [7] DIRECT ORAL ANTICOAGULANT THERAPY IN NONAGENARIANS PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION
    Bolognesi, M. G.
    Rossi, L.
    Maceda, D. Penela
    Pelizzoni, V.
    Pisati, M. S.
    Aschieri, D.
    Torretta, L.
    Villani, G.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E138 - E138
  • [8] DIRECT ORAL ANTICOAGULANT EDOXABAN IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: RESULTS OF DIRECT COMPARISON WITH WARFARIN
    Yavelov, I. S.
    [J]. KARDIOLOGIYA, 2020, 60 (08) : 124 - 129
  • [9] DISCONTINUATION/INTERRUPTION OF WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A763 - A763
  • [10] Characteristics of patients initiating oral anticoagulant therapy for management of non-valvular atrial fibrillation (NVAF)
    Masseria, C.
    Lin, I.
    Mardekian, J.
    Frean, M.
    Phatak, H.
    Kamble, S.
    Unniachan, S.
    Petkun, W.
    Abdulsattar, Y.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 1084 - 1084
12345